OpenFilings
Quince Therapeutics, Inc.
Form
8-K
Report Period
2026-05-17
Date Filed
2026-05-18
Time Filed
09:33:34
Document Analysis
Natural Language Processing
Recognized Type
Unidentified
Defined Term Format
Underlined
Italicized
Bold
Exhibits
8-K
EX-2.1
EX-3.1
EX-4.1
EX-10.1
EX-10.2
EX-10.3
EX-10.4
EX-10.5
EX-10.6
EX-99.1
EX-99.2
EX-99.3
Filing on SEC Edgar